Maraganore DM - Search Results

1

Clinical presentation and pharmacological therapy in corticobasal degeneration.

Kompoliti K, Goetz CG, Boeve BF, Maraganore DM, Ahlskog JE, Marsden CD, Bhatia KP, Greene PE, Przedborski S, Seal EC, Burns RS, Hauser RA, Gauger LL, Factor SA, Molho ES, Riley DE. Kompoliti K, et al. Among authors: maraganore dm. Arch Neurol. 1998 Jul;55(7):957-61. doi: 10.1001/archneur.55.7.957. Arch Neurol. 1998. PMID: 9678313 Clinical Trial.

2

Pathologic heterogeneity in clinically diagnosed corticobasal degeneration.

Boeve BF, Maraganore DM, Parisi JE, Ahlskog JE, Graff-Radford N, Caselli RJ, Dickson DW, Kokmen E, Petersen RC. Boeve BF, et al. Among authors: maraganore dm. Neurology. 1999 Sep 11;53(4):795-800. doi: 10.1212/wnl.53.4.795. Neurology. 1999. PMID: 10489043

3

Treatment of putative immune-mediated and idiopathic cervical dystonia with intravenous methylprednisolone.

Kumar R, Maraganore DM, Ahlskog JE, Rodriguez M. Kumar R, et al. Among authors: maraganore dm. Neurology. 1997 Mar;48(3):732-5. doi: 10.1212/wnl.48.3.732. Neurology. 1997. PMID: 9065556

4

Immunologic diseases, anti-inflammatory drugs, and Parkinson disease: a case-control study.

Bower JH, Maraganore DM, Peterson BJ, Ahlskog JE, Rocca WA. Bower JH, et al. Among authors: maraganore dm. Neurology. 2006 Aug 8;67(3):494-6. doi: 10.1212/01.wnl.0000227906.99570.cc. Neurology. 2006. PMID: 16894114

5

Fluctuating Parkinson's disease. Treatment with the long-acting dopamine agonist cabergoline.

Ahlskog JE, Muenter MD, Maraganore DM, Matsumoto JY, Lieberman A, Wright KF, Wheeler K. Ahlskog JE, et al. Among authors: maraganore dm. Arch Neurol. 1994 Dec;51(12):1236-41. doi: 10.1001/archneur.1994.00540240080020. Arch Neurol. 1994. PMID: 7986180 Clinical Trial.

6

Multicenter study of cabergoline, a long-acting dopamine receptor agonist, in Parkinson's disease patients with fluctuating responses to levodopa/carbidopa.

Lieberman A, Imke S, Muenter M, Wheeler K, Ahlskog JE, Matsumoto JY, Maraganore DM, Wright KF, Schoenfelder J. Lieberman A, et al. Among authors: maraganore dm. Neurology. 1993 Oct;43(10):1981-4. doi: 10.1212/wnl.43.10.1981. Neurology. 1993. PMID: 8105422 Clinical Trial.

7

Comparison of risk factor profiles in incidental Lewy body disease and Parkinson disease.

Frigerio R, Fujishiro H, Maraganore DM, Klos KJ, DelleDonne A, Heckman MG, Crook JE, Josephs KA, Parisi JE, Boeve BF, Dickson DW, Ahlskog JE. Frigerio R, et al. Among authors: maraganore dm. Arch Neurol. 2009 Sep;66(9):1114-9. doi: 10.1001/archneurol.2009.170. Arch Neurol. 2009. PMID: 19752300 Free PMC article.

8

Does levodopa therapy delay death in Parkinson's disease?

Uitti RJ, Ahlskog JE, Maraganore DM. Uitti RJ, et al. Among authors: maraganore dm. Mov Disord. 1996 May;11(3):343-4. Mov Disord. 1996. PMID: 8723162 No abstract available.

9

Intranasal apomorphine rescue therapy for parkinsonian "off" periods.

Dewey RB Jr, Maraganore DM, Ahlskog JE, Matsumoto JY. Dewey RB Jr, et al. Among authors: maraganore dm. Clin Neuropharmacol. 1996 Jun;19(3):193-201. doi: 10.1097/00002826-199619030-00001. Clin Neuropharmacol. 1996. PMID: 8726538 Clinical Trial.

10

Head trauma preceding PD: a case-control study.

Bower JH, Maraganore DM, Peterson BJ, McDonnell SK, Ahlskog JE, Rocca WA. Bower JH, et al. Among authors: maraganore dm. Neurology. 2003 May 27;60(10):1610-5. doi: 10.1212/01.wnl.0000068008.78394.2c. Neurology. 2003. PMID: 12771250 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

190 results

Search Page

Filters